Brazil Overrides Merck Patent on Aids Drug (New York Times)

The government, whose spending on AIDS drugs has skyrocketed as more patients have needed costly, patented medicines, overrode the patent held by the pharmaceutical company Merck on the antiretroviral drug efavirenz. The cost of Merck?s drugs has been $580 annually per patient. Brazil said the company had offered a 30 percent discount, but the government opted instead to buy the generic version …

Read more detail on Legal News Directory – Intellectual Property

Legal notice about the Brazil Overrides Merck Patent on Aids Drug (New York Times) rubric : Hukuki Net Legal News is not responsible for the privacy statements or other content from Web sites outside of the Hukuki.net site. Please refer the progenitor link to check the legal entity of this resource hereinabove.

Do you need High Quality Legal documents or forms related to Brazil Overrides Merck Patent on Aids Drug (New York Times)?

This entry was posted in Intellectual Property and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply